Emerald adds €1.66M for preventive healthcare
Emerald has secured an additional €1.66 million, split between grant funding and venture investment, bringing total funding to €3.44 million.
What happened
Emerald has secured an additional €1.66 million, comprising approximately €832,000 in grant funding and €832,000 in venture investment. The financing brings the company's total funding to €3.44 million.
Its platform combines laboratory screening, wearable data and medical history, with each member paired with a doctor who can diagnose, prescribe and make referrals.
Why it matters
Preventive-health services often provide test results without a clear clinical pathway. Emerald is trying to connect screening with medical interpretation, ongoing monitoring and follow-up care.
The bigger picture
The company will use the capital to expand commercially and develop AI-enabled tools that support more personalized preventive care.